• JPM22, Day 4: Vertex aims to be cystic fibrosis leader into the 2030s; Gritstone hopes for new colorectal cancer biomarker

    13 days ago - By Fierce Biotech

    JPM22, Day 4: Vertex aims to be cystic fibrosis leader into the 2030s; Gritstone hopes for new colorectal cancer biomarker chale
    Thu, 01/13/2022 - 08:25
    Read more ...